BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
Fine Organic’s overall 2QFY22 performance came in line with our estimates. However, compared to consensus estimates, Revenue/EBITDA/APAT came in higher by 11%/15%/18%.
Sequential improvement in EBITDA margin to the tune of 210bps is positive, in our view, and is a function of higher utilisation, pass-through of RM costs to an extent and pass-through of the freight impact to the customers in most cases.
Relatively reduced volatility in RMs should ensure better pass-through in the coming quarters.
Management sounded positive on the demand front, with pick-up in domestic demand.
Majority of the Specialty Ingredients companies have confirmed that demand in the domestic market picked up in 2QFY22.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.